Authors:
Gibson, CM
Murphy, SA
Rizzo, MJ
Ryan, KA
Marble, SJ
McCabe, CH
Cannon, CP
Van de Werf, F
Braunwald, E
Citation: Cm. Gibson et al., Is the corrected TIMI frame count an independent predictor of adverse outcome? Response, CIRCULATION, 102(2), 2000, pp. E19-E19
Authors:
Lepor, NE
Gross, SB
Daley, WL
Samuels, BA
Rizzo, MJ
Luko, SP
Hickey, A
Buchbinder, NA
Naqvi, TZ
Citation: Ne. Lepor et al., Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease, AM J CARD, 86(1), 2000, pp. 107
Authors:
Becker, RC
Hochman, JS
Cannon, CP
Spencer, FA
Ball, SP
Rizzo, MJ
Antman, EM
Citation: Rc. Becker et al., Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists - Observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study, J AM COL C, 33(2), 1999, pp. 479-487
Authors:
Gibson, CM
Murphy, SA
Rizzo, MJ
Ryan, KA
Marble, SJ
McCabe, CH
Cannon, CP
Van de Werf, F
Braunwald, E
Citation: Cm. Gibson et al., Relationship between TIMI frame count and clinical outcomes after thrombolytic administration, CIRCULATION, 99(15), 1999, pp. 1945-1950
Authors:
Gibson, CM
Ryan, KA
Kelley, M
Rizzo, MJ
Mesley, R
Murphy, S
Swanson, J
Marble, SJ
Dodge, JT
Giugliano, RP
Cannon, CP
Antman, EM
Citation: Cm. Gibson et al., Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results, AM HEART J, 137(6), 1999, pp. 1179-1184